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Identification of E-cadherin 
signature motifs functioning as 
cleavage sites for Helicobacter 
pylori HtrA
Thomas P. Schmidt1,*, Anna M. Perna2,*, Tim Fugmann3, Manja Böhm4,   Jan Hiss2, 
Sarah Haller2, Camilla Götz1, Nicole Tegtmeyer4, Benjamin Hoy1, Tilman T. Rau5,6, Dario Neri2, 
Steffen Backert4, Gisbert Schneider2,† & Silja Wessler1,†
The cell adhesion protein and tumour suppressor E-cadherin exhibits important functions in the 
prevention of gastric cancer. As a class-I carcinogen, Helicobacter pylori (H. pylori) has developed a 
unique strategy to interfere with E-cadherin functions. In previous studies, we have demonstrated that 
H. pylori secretes the protease high temperature requirement A (HtrA) which cleaves off the E-cadherin 
ectodomain (NTF) on epithelial cells. This opens cell-to-cell junctions, allowing bacterial transmigration 
across the polarised epithelium. Here, we investigated the molecular mechanism of the HtrA-E-
cadherin interaction and identified E-cadherin cleavage sites for HtrA. Mass-spectrometry-based 
proteomics and Edman degradation revealed three signature motifs containing the [VITA]-[VITA]-x-x-D-
[DN] sequence pattern, which were preferentially cleaved by HtrA. Based on these sites, we developed 
a substrate-derived peptide inhibitor that selectively bound and inhibited HtrA, thereby blocking 
transmigration of H. pylori. The discovery of HtrA-targeted signature sites might further explain why 
we detected a stable 90 kDa NTF fragment during H. pylori infection, but also additional E-cadherin 
fragments ranging from 105 kDa to 48 kDa in in vitro cleavage experiments. In conclusion, HtrA targets 
E-cadherin signature sites that are accessible in in vitro reactions, but might be partially masked on 
epithelial cells through functional homophilic E-cadherin interactions.
Chronic infections of humans by the pathogen and class-I carcinogen Helicobacter pylori (H. pylori) have been 
associated with several gastric disorders ranging from chronic gastritis and ulceration to lymphoma of the 
mucosa-associated lymphoid tissue (MALT) system and gastric cancer1,2. As the first target tissue, H. pylori per-
sistently colonises the epithelial lining of the human stomach, which represents an important barrier against 
toxins and pathogens. The organisation and maintenance of the gastric epithelium as a protective barrier require 
functional adherens junctions with the classical cadherin Cdh1 (E-cadherin) as a key molecule. Structurally, 
E-cadherin consists of five extracellular repeats (EC1-EC5), a single transmembrane domain (TMD) and an 
intracellular domain (IC). E-cadherin mediates intercellular adhesions between epithelial cells through dynamic, 
calcium-dependent, homophilic cis- and trans-interactions of its ectodomains3. The IC domain of E-cadherin 
binds to cellular proteins such as β -catenin, γ -catenin and p120-catenin, and bridges E-cadherin via α -catenin 
to the intracellular actin cytoskeleton. Beside their function in the adhesive E-cadherin complex, β -catenin and 
p120-catenin are also implicated in nuclear cancer-associated target gene expression. When released from the 
intracellular E-cadherin domain, β -catenin can accumulate in the cytoplasm and interfere with Wnt signalling, 
but can also translocate into the nucleus, where it can form a complex with transcription factors of the T-cell fac-
tor/lymphoid enhancer factor-1 (Tcf/LEF-1) family4,5. A similar role has been described for p120-catenin, which 
1Cancer Cluster Salzburg, Department of Molecular Biology, University of Salzburg, Austria. 2Department of 
Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH), Zurich, Switzerland. 3Philochem 
AG, Otelfingen, Switzerland. 4Division of Microbiology, University of Erlangen-Nuremberg, Germany. 5Institute 
of Pathology, University of Erlangen-Nuremberg, Germany. 6Institute of Pathology, University of Bern, Bern, 
Switzerland. *These authors contributed equally to this work.†These authors jointly supervised this work. 
Correspondence and requests for materials should be addressed to G.S. (email: gisbert.schneider@pharma.ethz.
ch) or S.W. (email: silja.wessler@sbg.ac.at)
received: 14 December 2015
Accepted: 02 March 2016
Published: 17 March 2016
OPEN
s
o
u
r
c
e
:
 
ht
tp
s:
//
do
i.
or
g/
10
.7
89
2/
bo
ri
s.
92
05
9 
| 
do
wn
lo
ad
ed
: 
13
.3
.2
01
7
www.nature.com/scientificreports/
2Scientific RepoRts | 6:23264 | DOI: 10.1038/srep23264
can relieve Kaiso-dependent transcriptional repression in the nucleus6,7. Therefore, an intact E-cadherin complex 
plays a significant role in cell-to-cell adhesion and prevention of invasive growth and metastasis of many tumour 
types8.
H. pylori-associated metastatic gastric cancer (GC) is the leading cause of cancer-related deaths worldwide 
because effective treatment strategies are missing. Both the diffuse and intestinal GC types have been correlated 
with an altered functionality of the E-cadherin complex. The most prominent mechanisms in the gastric system 
include (i) loss-of-function mutation of the cdh1 gene9,10, (ii) epigenetic down-regulation of E-cadherin expres-
sion11,12 and/or (iii) shedding of the E-cadherin ectodomain13. The proteases involved and their substrate cleavage 
patterns are still not entirely known. E-cadherin ectodomain cleavage was originally observed in breast cancers14. 
The soluble ~90 kDa N-terminal E-cadherin fragment (NTF) has been associated with a broad range of cancers 
and correlates with the grade, number and recurrence of certain tumours15. E-cadherin-cleaving enzymes com-
prise various host cell metalloproteases (e.g. MMP-3, -7, -9, ADAM-10, -15)16–19 and the protease HtrA (high 
temperature requirement A), both of bacterial and human origin20,21.
Serum levels of soluble E-cadherin are increased in the intestinal GC-type and might serve as a biological 
marker22. It has been previously shown that H. pylori induces strong E-cadherin shedding, which leads to the 
disruption of adherens junctions23. H. pylori-activated ADAM-10 (a disintegrin and metalloprotease) has been 
suggested to be responsible for the cleaving of E-cadherin on host cells24. However, we found that inhibition of 
a wide range of matrix metalloproteases (MMPs) together with siRNA-mediated downregulation of ADAM-10 
only slightly decreased H. pylori-mediated E-cadherin shedding, while a major contribution of H. pylori HtrA 
was detected21. In fact, HtrA is a secreted bacterial serine protease that, together with host proteases, directly tar-
gets E-cadherin exposed on the surface of gastric epithelial cells21. The biological significance of HtrA-mediated 
E-cadherin cleavage has also been shown for the Gram-negative pathogens Campylobacter jejuni (C. jejuni), 
enteropathogenic Escherichia coli (EPEC) and Shigella flexneri of the gastrointestinal tract20,25,26, indicating that 
E-cadherin represents a primary target in bacterial pathogenesis.
HtrA has already been intensively investigated in E. coli expressing the three HtrA homologues DegP, DegQ 
and DegS. The main function of bacterial HtrA is protein quality control and degradation of misfolded proteins 
in the periplasm, enhancing bacterial survival under stress conditions. In fact, H. pylori HtrA is highly active 
under extreme conditions27, indicating that it is important for bacterial physiology in the environment of the 
stomach. This is supported by the finding that the htrA gene is essential and cannot be deleted or mutagenised in 
the H. pylori genome21,28,29. The observation that secreted H. pylori HtrA directly affects the integrity of the gas-
tric epithelium via E-cadherin ectodomain shedding implies that truncated E-cadherin could also interfere with 
H. pylori-induced signalling in GC.
Previous studies investigating MMP-mediated E-cadherin cleavage and Edman sequencing of E-cadherin 
fragments have suggested the residue pattern L585↓S↓D587 (CDH1, P12830) in the EC4 domain as a target site17. In 
another study, P700↓V701 was proposed as an MMP cleavage site19. Whether H. pylori HtrA targets the same sites or 
prefers another amino acid sequence is unknown, but this information is crucially important for understanding 
the HtrA-E-cadherin interaction and developing HtrA inhibitors.
In the present study, we investigated the molecular mechanism of the HtrA-E-cadherin interaction. We 
discovered that E-cadherin signature motifs function as target sites for the proteolytic degradation by HtrA, 
leading to a defined fragmentation pattern of E-cadherin. As HtrA-mediated E-cadherin shedding may pos-
sess cancer-promoting properties, we used the identified signature sites to design the first substrate-based pep-
tide inhibitor to impede HtrA-mediated E-cadherin cleavage and H. pylori transmigration across a polarised 
monolayer.
Results
H. pylori HtrA mediates different cleavage patterns of E-cadherin in vitro and on gastric epi-
thelial cells. Several pathogenic bacteria secrete the HtrA protease, which cleaves off the extracellular NTF 
domain of E-cadherin on epithelial host cells to open intercellular junctions20,21,25,26. However, it is completely 
unknown how HtrA interacts with E-cadherin at the molecular level. The aim of this study was the identification 
of HtrA cleavage sites as the basis for the future generation of potential pharmacological tools. Mature human 
E-cadherin (hCdh1) is expressed as a 125 kDa glycoprotein, which consists of the five extracellular domains EC1–
EC5, a linker region, a single transmembrane domain (TMD) and an intracellular (IC) domain (Fig. 1A, hCdh1 
D155–D882). Several antibodies are available that selectively recognise individual domains of the E-cadherin pro-
tein. SHE78-7 detects the EC1 domain, the HecD1 antibody recognises the EC2 domain and H108 binds to the 
EC5 domain19,30. The specificity and selectivity of these antibodies was confirmed by using deletion mutants of 
recombinant E-cadherin lacking the EC1, EC1–2, EC1–3, EC4–5 and EC5 domains (see Supplementary Fig. S1A, 
Fig. S1B, Table S1). To investigate the fragmentation of E-cadherin, NCI-N87 cells were infected with H. pylori for 
the indicated time periods and aliquots of the supernatants were analysed for E-cadherin fragments containing 
the EC1, EC2 or EC5 domain. After 16 h of infection, the anti-EC1 antibody detected a strong increase in the 
90 kDa NTF fragment of E-cadherin (hCdh1NTF). We observed a similar picture for the anti-EC2 antibody. When 
the supernatant was analysed with the anti-EC5 antibody, the hCdh1NTF fragment enriched during H. pylori 
exposure was already visible after 4 h of H. pylori exposure and the levels increased during the 16 h of infection 
(Fig. 1B, upper panels). Further fragments were not detectable, even after longer exposures of the membranes 
(not shown). These results indicate that H. pylori induces production of a stable 90 kDa hCdh1NTF fragment which 
contains the EC1 to EC5 domains. Although H. pylori adhered slightly more strongly to AGS than to MKN-28 
or NCI-N87 cells (see Supplementary Fig. S1C), the formation of a stable 90 kDa fragment of E-cadherin in the 
supernatants was reproducibly detected for all cell lines (Fig. 1B, see Supplementary Fig. S1D). Corresponding 
to the increase in the 90 kDa hCdh1NTF, we observed a significant drop in signals for the 125 kDa full-length 
E-cadherin protein (hCdh1FL) in lysates of H. pylori-infected NCI-N87 cells (Fig. 1B, middle panels). A slight 
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decrease in hCdh1FL could be detected using the anti-EC1, anti-EC2 and anti-EC5 antibodies during early time 
periods of H. pylori infections and an obvious loss of hCdh1FL was visible after 16 h. An anti-IC antibody con-
firmed these results, with β -actin as loading control (Fig. 1B, lower panels).
E-cadherin forms functional cis- and trans-interactions between the extracellular domains of two neigh-
bouring cells3 which could overlay additional cleavage sites. Therefore, we examined fragment formation using 
a recombinant E-cadherin chimera (rCdh1 D155–I707). rCdh1 contains the five EC domains and the linker region 
(A698–I707), but lacks the TMD. Instead of the IC domain, rCdh1 is fused to the Fc region and a His6 tag (Fig. 1A, 
rCdh1 D155–I707). Incubation of rCdh1 with recombinant H. pylori HtrA (rHtrA) for the indicated time periods 
showed a different cleavage pattern compared to the H. pylori infection experiments. Using the anti-EC1 anti-
body, we only detected the loss of the full-length E-cadherin protein (rCdh1FL) (Fig. 2A). Even after long expo-
sure, the Western blots did not reveal further fragments, suggesting an immediate loss of the EC1 domain (see 
Supplementary Fig. S2). The anti-EC2 antibody detected an additional high molecular weight (~110 kDa) frag-
ment (Fig. 2A, see Supplementary Fig. S2). A ladder of putative E-cadherin fragments of approximately 105 kDa, 
90 kDa, 60 kDa and 48 kDa was observed using the anti-EC5 antibody (Fig. 2A). Similar fragments appeared 
when an anti-His tag antibody was applied (Fig. 2A, see Supplementary Fig. S2), indicating that fragmentation of 
E-cadherin begins at the N-terminus with the cleaving of individual EC domains (Fig. 2B). According to the frag-
ment sizes observed during H. pylori infections and in in vitro cleavage experiments, we suggest that E-cadherin 
is N-terminally and C-terminally processed by HtrA. Upon H. pylori infection, a stable 90 kDa NTF originating 
Figure 1. Formation of a stable 90 kDa E-cadherin fragment after infection with H. pylori. (A) Domain 
structures of human endogenous E-cadherin (hCdh1) and recombinant E-cadherin (rCdh1). E-cadherin 
consists of five extracellular domains (EC1–EC5) and a linker region. hCdh1 contains a transmembrane domain 
(TMD) and an intracellular domain (IC). rCdh1 is expressed as a Fc-tag/His6 fusion protein. The monoclonal 
antibodies recognise the EC1 (SHE78-7) or the EC2 domain (HecD1). The polyclonal antibody H108 is directed 
against the EC5 domain. (B) NCI-N87 cells were infected with H. pylori at a MOI of 100 (+) for the indicated 
time periods or left untreated (−). E-cadherin fragments in the supernatant (upper panels) and in the lysates 
(lower panels) of infected cells were detected using antibodies recognising the EC1, EC2, EC5, or the IC 
domains. β -actin was detected as a control.
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from hCdh1 is formed, while in in vitro cleavage experiments, rCdh1 is mainly N-terminally processed resulting 
in a series of different fragments (Fig. 2B).
Identification of HtrA cleavage sites in E-cadherin. To identify the HtrA cleavage sites in E-cadherin, 
we performed a label-free mass spectrometry-based proteomic analysis of HtrA/trypsin digests of rCdh1. 
Overall, we detected 128 peptides of E-cadherin origin, among which we identified 46 semi-tryptic peptides that 
were processed solely by HtrA at the non-tryptic cleavage site. These peptides were commonly cleaved after the 
residues I (37%), V (28%), T (17%), A (9%) and S (9%). Sequence analysis revealed that HtrA cleavage takes place 
favourably between hydrophobic amino acids (Fig. 3A,B). We also performed N-terminal Edman sequencing 
of rCdh1 cleavage products to validate the cleavage pattern obtained from the same recombinant Cdh1 protein. 
These results agree with the mass spectrometric analysis. Four of five detected N-terminal cleavage sites (T↓T, 
A↓K, V↓A, I↓T, A↓G) match the proteomic cleavage site pattern [VITA]↓[VITA]-x-x-D-[DN], which are located 
within the four calcium-binding sites and which we have named “signature sites” S1, S2, S3 and S4 (Fig. 3C). The 
signature site S3 between EC3 and EC4 was less frequently targeted by HtrA. This consensus cleavage pattern for 
HtrA-catalysed proteolysis is related to that of its E. coli orthologue DegP, which also favourably cleaves between 
hydrophobic residues31. We further observed that HtrA cleaved most frequently in the fourth signature sequence 
of E-cadherin (Fig. 3B). Its I↓L cleavage site was detected with the highest intensity of all peptides.
Identification of substrate-derived inhibitory peptides. Since deletion or mutation of the htrA 
gene in the H. pylori genome is not possible, we aimed at the generation of a peptide-based E-cadherin cleavage 
inhibitor. We synthesised five peptides (P1− P5) around the cleavage signature sequence between E-cadherin 
domains EC4 and EC5 (positions L583–P593) (Fig. 3C, see Supplementary Fig. S4A). The 21-residue peptide P1 (see 
Supplementary Fig. S3A, Fig. S4A) effectively inhibited in vitro HtrA-mediated E-cadherin cleavage (Fig. 4A). 
Shorter peptides (see Supplementary Fig. S4A) did not exhibit any suppressive effect (Fig. 4A,B). The direct bind-
ing affinities of the peptides to immobilised HtrA were measured by surface plasmon resonance (SPR). Peptide P1 
showed strong binding, while only one other cleavage-sequence peptide (P5) evoked a positive binding response 
Figure 2. HtrA-mediated fragmentation of E-cadherin in in vitro cleavage experiments. (A) 100 ng 
recombinant E-cadherin was incubated with 200 ng recombinant HtrA at 37 °C for the indicated time periods. 
E-cadherin fragments were detected using antibodies recognising the EC1, EC2 or EC5 domains, or the 
C-terminal His6 tag. HtrA is shown as a control. (B) Detected E-cadherin fragments after infection with  
H. pylori (hCdh1) or in vitro cleavage (rCdh1). Putative cleavage sites are indicated by an open arrow. The black 
arrow indicates the possible cleavage site leading to EC5-containing fragments.
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above the significance threshold (Fig. 4C). N-terminal truncation of the P1 peptide led to a loss of enzyme inhi-
bition, indicating that the N-terminal part of P1 is important for substrate recognition by HtrA. In a competition 
experiment, we analysed the short peptide P1_NT, which contains the hydrophobic amino acid stretch TGTLLLI. 
As controls, P1_NT (TG) and P1_NT (GT) were included as scrambled 7-residue peptides (see Supplementary 
Fig. S4A). None of these peptides blocked HtrA-induced E-cadherin cleavage or interfered with P1-mediated 
HtrA inhibition (see Supplementary Fig. S4B). We then substituted key amino acids in the C-terminal (P1_CTmut) 
or N-terminal (P1_NTmut) regions with glycine (see Supplementary Fig. S4A). Both P1_CTmut and P1_NTmut only 
partially inhibited HtrA-mediated E-cadherin cleavage (see Supplementary Fig. S4C). Therefore, we postulate 
that the 21-residue P1 peptide is required for efficient HtrA inhibition. We also synthesised P1 with a C-terminal 
alpha-amide and subjected both P1 variants (P1-OH, P1-NH2) to SPR analysis. Although both peptides exhib-
ited concentration-dependent binding (see Supplementary Fig. S3B, Fig. S3C), the P1-peptide with the natural 
C-terminal carboxylic acid evoked stronger SPR signals, reflecting its binding capacity to HtrA (Fig. 4D). This 
result is in agreement with a study by Krojer et al., who compared peptide substrates of the E. coli orthologue 
DegP32.
Peptide P1 strongly inhibited HtrA-mediated rCdh1 cleavage in a concentration-dependent manner (Fig. 5A). 
To investigate the bioactivity of P1, we quantitated the inhibition of HtrA in H. pylori-infected AGS cells that were 
transfected with hCdh1FL. We observed a significant dose-dependent decrease in the formation of the hCdh1NTF 
(Fig. 5B) in comparison with the corresponding loading controls (see Supplementary Fig. S4D). This effect was 
also observed in H. pylori infections of several other cell lines and at different infection doses (data not shown). 
We then analysed the epithelial transmigration of H. pylori in a transwell filter assay. Partially polarised MKN-28 
Figure 3. Identification of signature sites. (A) Sequence logo and hydrophobicity of HtrA cleavage sites in 
E-cadherin. The height of the amino acid one-letter codes illustrates their relative observed frequency. The 
local cleavage site residue pattern is [VITA]↓ [VITA]-x-x-D-[DN]. (B) HtrA-cleavage sites of E-cadherin 
peptides. The triangles denote the non-tryptic cleavage positions found by label-free mass spectrometry-
based proteomic analysis of combined HtrA/tryptic digests. Their colour illustrates the signal intensity of the 
detected peptides. The amino acids drawn in blue designate fully tryptic peptides. Cleavage sites found by 
N-terminal Edman sequencing are shown as underlined residues. The amino acids drawn in grey are not a part 
of E-cadherin (linker, Fc domain of IgG1). The cadherin domain signature [LIV]-x-[LIV]-x-D-x-N-D-[NH]-
x-P is highlighted within a box. The P1 peptide is shown in a dashed box. (C) Comparative model of human 
E-cadherin (template PDB-ID: 3Q2V chain A) with its five EC domains. The experimentally detected signature 
sequence stretches are shown as coloured balls (turquoise) to contrast them to the grey ribbon representing 
the EC domains. Different colouring of the flanking regions (in magenta) of S4 shows the overhanging parts of 
peptide P1.
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cell monolayers were infected and the transmigration of E-cadherin-cleaving H. pylori was determined over time. 
Polarisation of MKN-28 cells requires functional tight junctions, which can be monitored by the measurement of 
the transepithelial electrical resistance (TEER). Corresponding to previous studies21,25,33,34, MKN-28 cells showed 
partial polarisation, as reflected by a resistance of ∼ 150 Ω/cm2 after 14 days of cultivation (see Supplementary 
Fig. S5A). Infections with H. pylori (see Supplementary Fig. S5B) did not significantly alter the polarisation of 
host cells. However, we observed a strong concentration-dependent reduction of H. pylori transmigration by P1 
(Fig. 5C), indicating that P1 efficiently blocks HtrA-mediated E-cadherin cleavage. These results confirm the 
bioactivity of P1 as the first inhibitory peptide blocking bacterial HtrAs.
Discussion
E-cadherin is an important cell adhesion molecule and tumour suppressor. Ectodomain shedding and an increase 
in soluble E-cadherin is associated with several cancer types, such as breast cancer, pancreatic cancer and GC15. 
In recent years, several E-cadherin-cleaving proteases have been described. MMPs, such as MMP-7 (matrilysin)35 
and MMP-3 (stromelysin-1)36, or proteases such as ADAM-1037 are examples that cleave off the extracellular 
E-cadherin domain. In H. pylori-infected cells, activated ADAM-10 (a disintegrin and metalloprotease) has been 
suggested as a protease responsible for the cleavage of E-cadherin on host cells24. Furthermore, H. pylori induces 
the expression of several MMPs, including MMP-3 and MMP-7, which can also contribute to E-cadherin shed-
ding21,24. Recently, HtrA was added to this collection as the first E-cadherin-cleaving protease expressed by H. 
pylori21. Generally, knowledge of H. pylori proteases is still rare and no additional H. pylori protease has yet been 
identified as an E-cadherin-cleaving protease. H. pylori expresses an active collagenase (Hp0169), which is cru-
cially important for in vivo colonisation38, but this has not been tested for E-cadherin cleavage. Previous studies 
have predicted several putative H. pylori proteases with an extracellular localisation39,40. Among these, Hp0506 is 
required for bacterial cell shape and pole formation41, but, like Hp0657 and Hp1012, it does not target E-cadherin 
as a substrate21. Since E-cadherin acts as an important suppressor of carcinogenesis, increased understanding of 
Figure 4. Development of a signature site-based peptide inhibitor. (A,B) E-cadherin cleavage by HtrA in the 
presence of 100 μM peptides P1, P2, P3, P4 and P5. P1 efficiently inhibited HtrA-mediated E-cadherin cleavage. 
Different sections of the same membrane with samples analysed under the same experimental conditions are 
shown in (B). The original Western blot image is shown in Fig. S6. (C) Measurement of direct peptide binding 
to HtrA by SPR. The dotted line represents the activity threshold. (D) The P1 peptide with a free carboxyl 
C-terminus (P1-OH, filled circles) evoked a greater SPR response than its amide counterpart (P1-NH2, open 
circles).
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the direct interaction between HtrA and E-cadherin is required. Therefore, we report here on a comprehensive 
cleavage site map for E-cadherin and the development of an effective peptide inhibitor based on an HtrA-targeted 
substrate sequence.
For MMPs, the amino acid sequence L585↓S↓D587 in the EC4 domain and P700↓V701 have been suggested as 
putative cleavage sites17,19. In our study, we identified the [LIV]-x-[LIV]-x-D-x-N-D-[NH]-x-P sequence pattern 
in the E-cadherin molecule as a target for H. pylori HtrA, which is in line with the L585↓S↓D587 cleavage site for 
MMPs17. This sequence pattern is located in three out of four calcium-binding regions of the E-cadherin mole-
cule, which we have designated as signature sites S1, S2, S3 and S4. The accessibility of E-cadherin signature sites 
as cleavage sites for H. pylori HtrA and possibly for H. pylori-regulated MMPs might explain why we observed 
different fragmentation patterns in H. pylori infections and in vitro (Fig. 6). We included several different gastric 
epithelial cell lines in our study, which might be differentially colonised by H. pylori. It had been previously shown 
that H. pylori infection of MKN-28 cells induces the formation of the stable 90 kDa NTF20,21. Although AGS 
cells showed a slightly stronger binding of H. pylori in comparison to MKN-28 and NCI-N87 cells, an unaltered 
fragmentation pattern was detected, as reflected by the stable 90 kDa NTF. These data indicate that possible differ-
ences in H. pylori adherence to host cells do not influence E-cadherin shedding by secreted HtrA, while cis and/or 
trans interactions of E-cadherin might be important. The interaction of the ectodomains at the molecular level is 
still not fully understood, but has been described as a highly dynamic process3. It has been suggested that the EC1 
domain forms an initial weak intercellular adhesion, while strong adhesion requires at least EC1–342 (Fig. 6). In 
in vitro cleavage experiments, rCdh1 likely exists as a monomer that presents all signature sites as possible cleav-
age sites (Fig. 6). In contrast, epithelial cells form functional E-cadherin-mediated adhesions through cis and 
Figure 5. Inhibition of HtrA-mediated E-cadherin cleavage. (A) 50 ng rCdh1 was incubated with 200 ng 
HtrA and indicated concentrations of P1. rCdh1 fragments and HtrA were detected using specific antibodies. 
(B) Transfected AGS cells expressing hCdh1 were infected with H. pylori (Hp) or left untreated (–) for 16 h. 50 μl 
aliquots of the supernatants were separated by SDS PAGE and blotted onto membranes. The 90 kDa hCdh1NTF 
fragment was detected by Western blots. The relative amount of hCdh1NTF fragment was quantified by blot 
densitometry from three independent experiments. These results are given as arbitrary units with the hCdh1NTF 
fragment levels produced in response to H. pylori which were not treated with P1 set to 100%. (C) Polarised 
MKN-28 cells grown on transwell filters were infected with H. pylori in the presence and absence of peptide 
P1 at different concentrations (100 μM, 200 μM, 500 μM). Bacteria that had transmigrated across the MKN-28 
monolayer on the filter were counted (n = 3, mean ± std dev).
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trans interactions of the extracellular E-cadherin domains. This tight binding might overlay the signature sites 
S1 to S3 and probably S442,43, or induce changes in their structural accessibilities. In this model, H. pylori could 
still target the S4 signature site or an undiscovered cleavage site in the linker region leading to the formation of 
the 90 kDa fragment (Fig. 6). Due to the glycosylation of E-cadherin, the size of the E-cadherin sequence from 
D155 to the S4 site is not definitively assessable. Therefore, we cannot exclude the possibility that HtrA also targets 
a sequence in the linker region near the transmembrane domain which was not detectable after tryptic digests. 
In conclusion, we have identified signature sites in the E-cadherin protein that are cleaved by H. pylori HtrA 
leading to the fragmentation of E-cadherin, depending on the cis and trans interactions between the extracellular 
domains.
Since an htrA knock-out H. pylori mutant is still lacking, we focused on pharmacological inhibition of 
H. pylori HtrA. Several small molecule compounds targeting H. pylori HtrA have been successfully developed 
which can function as lead structures21,44–46. Here, we present the first substrate-derived peptide that efficiently 
binds and inhibits H. pylori HtrA. The P1 peptide TGTLLLILSDVNDNAPIPEPR corresponds to the E-cadherin 
sequence T578–R598 surrounding the signature site S4. The P1 peptide binds with high specificity and efficiently 
blocked E-cadherin cleavage in vitro. The inhibitory effect of P1 in H. pylori infections was weaker, but still 
significant at higher concentrations. The bioactivity of P1 was further confirmed by the inhibition of H. pylori 
transmigration. Although not investigated in this study, the P1 peptide might be captured by other E-cadherin 
binders or might be degraded. Although our data provide direct evidence for HtrA inhibition by the P1 peptide, 
which corroborates the idea that HtrA enzymatic activity is critical for E-cadherin cleavage, an optimisation of 
substrate-based inhibitors is still necessary.
E-cadherin could play a central role in H. pylori-dependent invasiveness of tumour cells, which is indicated 
by the finding that the H. pylori virulence factor cytotoxin-associated gene A (CagA) can interact with the IC 
Figure 6. Model of the HtrA-induced E-cadherin cleavage pattern. E-cadherin contains four signature 
motifs, of which HtrA preferentially cleaves the three sequences S1, S2 and S4 ⇦ in vitro. An additional cleavage 
site might be located in the linker region (black arrow). On epithelial cells, the E-cadherin ectodomains interact 
in cis and in trans forming functional cell-to-cell adhesions. The extent of overlapping domains determines the 
accessibility of cleavage site for HtrA.
www.nature.com/scientificreports/
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of E-cadherin, interfering with its tumour-suppressing function47,48. It would be compelling to investigate if 
truncated E-cadherin still binds the intracellular catenin complex or CagA, and if catenin signalling is affected. 
Importantly, the soluble 90 kDa NTF fragment of E-cadherin does not only serve as a biomarker for GC49, but 
can also impair cell adhesions in a paracrine manner35. These data imply that gastric E-cadherin ectodomain 
shedding is also important in H. pylori-dependent carcinogenesis. In conclusion, our results provide an inspiring 
novel entry point for innovative anticancer drug discovery.
Methods
Cell culture and infection experiments. The human gastric adenocarcinoma cell line AGS is E-cadherin-
negative and was derived from an adenocarcinoma of the stomach of a 54 year-old Caucasian female (ECACC, 
89090402). AGS cells expressing hCdh1 were generated by transfection using a plasmid containing E-cadherin 
wild-type cDNA50 which has been kindly provided by Rohan D. Teasdale (University of Queensland, Australia). 
E-cadherin-positive MKN-28 cells (JCRB, 0253, obtained from the Max-Planck Institute for Infection Biology) 
were originally described as being isolated from a moderately differentiated tubular adenocarcinoma and have 
been frequently used to study E-cadherin-dependent processes20,21,23,25. The gastric epithelial NCI-N87 cells 
(ATCC, CRL-5822) were included as an additional E-cadherin-expressing cell line24 and were derived from 
metastasis in the liver. All cells have been described previously24,51 and were grown in RPMI 1640 medium 
containing 4 mM glutamine (Invitrogen) and 10% FCS (Sigma) in a humidified atmosphere at 37 °C. H. pylori 
wild-type strains P1252 and Hp2669553 were cultured on agar plates containing 10% horse serum under microaer-
ophilic conditions for 48 h at 37 °C before infection experiments. Cells were infected with H. pylori at a MOI of 
100. Adherence of H. pylori was quantitated in a cfu (colony-forming unit) assay. Briefly, bacteria were suspended 
in culture medium, added to the cells at a MOI of 100 and co-incubated with host cells for 16 h. The number of 
cfu was determined by growth on agar plates for 72 h. To investigate the influence of the P1 inhibitor peptide on 
bacterial transmigration, transwell infections were performed in the presence or absence of 100, 200 or 500 μM 
peptide. The human gastric adenocarcinoma cell line MKN-28 was grown to confluence on transwell filters and 
polarised for 14 days. Establishment of functional tight epithelial cell monolayers was further confirmed by meas-
uring the transepithelial electrical resistance (TEER). Infection of these cells was carried out with bacteria at a 
MOI of 50 for the indicated periods of time per experiment. The number of transmigrated bacteria was deter-
mined as cfu by taking aliquots from the basal chambers21,54. All infection assays were done in triplicate.
Western blotting. Proteins were separated by SDS PAGE and analysed by Western blot using specific anti-
bodies against HtrA21, the extracellular domains EC5 (H108, Santa Cruz Biotechnology and ab40772, Abcam), 
EC1 (SHE78-7, Invitrogen) and EC2 (HecD1, Calbiochem) of E-cadherin, or the intracellular domain (24E10, 
Cell Signaling). His6-tagged proteins were analysed using an anti-His5-antibody (Qiagen). GAPDH (Cell 
Signaling) and β -actin (Sigma) were detected as loading controls. Where indicated, signals of protein bands were 
quantified using the ImageLab software (BioRad). Graphical presentation and statistical evaluations (Student’s 
t-test) were performed with GraphPad Prism 5 and p-values of ***p ≤ 0.001, **p ≤ 0.01 and *p ≤ 0.05 were con-
sidered statistically significant.
In vitro HtrA proteolytic activity. Purification of recombinant H. pylori HtrA and in vitro cleavage assays 
have been described elsewhere21,39. Briefly, 200 ng recombinant HtrA was incubated with 50 ng recombinant 
hCdh1 (R&D Systems) in 50 mM HEPES pH 7.4 and 100 μM EDTA for 16 h (or for the indicated time periods) at 
37 °C. Where indicated, test peptides were added.
Samples for combined HtrA and tryptic digestion. Tryptic digestion was performed on three differ-
ent samples (sample volume: 200 μl). Sample 1 contained human recombinant E-cadherin Fc His6 (22.5 ng/μl 
E-cadherin D155–I707, R&D Systems) in 50 mM HEPES buffer (HEPES buffer 1 M solution, pH 7.3, Fisher Scientific), 
0.5 mM MgCl2 (Sigma-Aldrich Chemie GmbH) and 1 mM CaCl2 (Sigma-Aldrich Chemie GmbH, pH 7.3). 
Sample 2 contained HtrA (2.5 ng/μl in 50 mM HEPES buffer, pH 7.3). Sample 3 included HtrA and human recom-
binant E-cadherin Fc His6 at a ratio of 1:10 (2.5:22.5 ng/μl in 50 mM HEPES buffer, pH 7.3). All samples were 
incubated for 12 h at 37 °C in a horizontal shaker. Samples 1 and 2 were applied in sextuplicate, and sample 3 
was done in triplicate. Finally, 2 μl of sequencing-grade modified porcine trypsin was added (stock solution of 
50 ng/μl in 50 mM HEPES, 1 mM CaCl2, pH 7.3, Promega). Protease digestion was carried out overnight at 37 °C 
in a horizontal shaker. After tryptic digestion, Samples 2 and 1 were mixed at a ratio of 1:10 to obtain Sample 4. 
Peptides were desalted, purified and concentrated using C18 microcolumns OMIX tips (Agilent Technologies). 
After lyophilisation, peptides were stored at –20 °C.
Nanocapillary HPLC with automated on-line fraction spotting onto MALDI target 
plates. Peptides were separated by reverse-phase high-performance liquid chromatography using an 
EASY-nLC system (Proxeon, now Thermo Fisher Scientific) with mobile phase A: 0.1% trifluoroacetic acid (TFA) 
in water; mobile phase B: 0.1% TFA in acetonitrile; flow rate of 300 nl/min. Lyophilised peptides were dissolved 
in 23 μl of buffer A, of which 18 μl were loaded onto the column (inner diameter = 75 μm; length = 15 cm; filled 
with ReproSil-Pur C18 AQ, 3 μm, 120 Å beads; Dr. Maisch GmbH). The peptides were eluted with a gradient 
of 5–33% B for 62 min, 33–48% B for 15 min, 48–100% B for 2 min and 100% B for 10 min. The column was 
then equilibrated with 5% B for 20 min before the next sample was analysed. Eluting fractions were mixed with 
a solution of 3 mg/ml α -cyano-4-hydroxycinnamic acid, 187.5 pmol/ml of each of the four internal standard 
peptides ([des-Arg9]-bradykinin, neurotensin, angiotensin I and adrenocorticotropic hormone fragment 1–17; 
all from Sigma), 0.1% TFA and 70% acetonitrile in water and deposed on a blank MALDI target plate (416 spots 
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per sample) using an online SunCollect system (SunChrom). The final concentration of each internal peptide 
standard was 50 fmol per spot.
Mass spectrometric analysis. MALDI-TOF/TOF analysis was carried out with a 4800 MALDI TOF/TOF 
Analyzer (AB SCIEX). All spectra were acquired with a solid-state laser (355 nm) at a laser repetition rate of 
200 Hz. After measuring all samples in the MS mode, a maximum of 12 precursors per spot were automati-
cally selected for subsequent fragmentation by CID using the mass spectrometer control software (4000 Series 
Explorer V3.7, AB SCIEX). The resulting spectra were processed and analysed using the Global Protein Server 
Workstation version 3.6 (GPS Explorer, AB SCIEX), which uses internal MASCOT version 2.1 (Matrix Sciences) 
software for matching MS and MS/MS data against databases of in silico-digested proteins. Both fully tryptic 
and semi-tryptic peptides were taken into account. MS/MS data was searched against a database consisting of 
H. pylori HtrA (UniProt ID: G2J5T2)55, glutathione S-transferase class-mu 26 kDa isozyme from Schistosoma 
japonicum (UniProt ID: P08515), human recombinant E-cadherin Fc His6 and typical contaminants from 
recombinant protein expression (yielding a total of 27455 proteins). Possible contaminants included amino acid 
sequences of human keratins, Escherichia coli and proteins from foetal calf serum downloaded from UniProt 
(www.uniprot.org). The following analysis settings were used for the identification of peptides and proteins: (i) 
precursor tolerance: < 15 ppm, (ii) MS/MS fragment tolerance: 0.5 Da, (iii) maximal missed cleavages: 1, (iv) 
one variable modification (oxidation of methionine). Peptides were considered correct calls if the confidence 
interval exceeded 95%. After MS acquisition, the data related to the individual peaks (fractions, intensities, 
mass-to-charge ratios) were loaded into the DeepQuanTR software56, which performed a normalisation of indi-
vidual signal intensities to the internal standard peptides and an annotation (peptide identification and associ-
ation with a parent protein). Normalised intensities for the individual peptides from all samples of each group 
(Samples 1–4) were used for the computation of DeepQuanTR peptide and protein scores, indicating the relative 
abundance of individual peptides and proteins in the sample groups.
N-terminal sequencing. Edman sequencing was performed on an acid-etched glass fibre disk or on a PVDF 
membrane of an ABI Procise 494 sequencer. Prominent E-cadherin cleavage product bands of the HtrA cleavage 
assay were eluted and N-terminal sequencing was performed by Alphalyse A/S (Odense).
Peptide synthesis and analytics. Peptide synthesis was performed on robotic solid-phase peptide syn-
thesisers (OvertureTM and SymphonyTM, Protein Technologies) utilising Fmoc-protected amino acids (AAPPTec) 
and Fmoc-Wang-resin (AAPPTec). Deprotection was performed for > 2 min with 20% piperidine (Sigma-Aldrich 
Chemie GmbH) or 20% pyrrolidine (Sigma-Aldrich Chemie GmbH) in DMF (dimethylformamide, 
Sigma-Aldrich Chemie GmbH). A coupling reagent of amino acid, HCTU (O-(6-chloro-1-hydrocibenzotriazol-
1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate, AAPPTec) and NMM (4-methylmorpholine, Fisher 
Scientific AG) in DMF was used for double coupling (min. 2 × 5 min), multiple washing steps after deprotec-
tion and double coupling. A cleavage reagent of TFA (2,2,2-trifluoroacetic acid, Fisher Scientific AG), H2O 
and TIPS (triisopropylsilane, Sigma-Aldrich Chemie GmbH) was used for automated cleavage. Peptides were 
isolated by using ice-cold diisopropylether (Sigma-Aldrich Chemie GmbH), rewashed there times, dried 
and stored at –20 °C. For peptide analytics, a linear gradient of 5–70% ACN/H2O(0.1% TFA) (acetonitrile, 
Sigma-Aldrich Chemie) over 25 min with a flow rate of 0.5 ml/min on a rpC18, 110 Å, 5 μm, 150 × 3 mm column 
(Macherey-Nagel) was used on a LC-20A HPLC instrument (Shimadzu). Mass identification was performed 
by a Shimadzu LCMS-2020 single-quad mass spectrometer (ESI+) at an interval of 300–1500 Da. Calculated 
molecular weights (mw, unit: Da), detected retention times (Rt, unit: minutes) and observed masses (m+ , unit: 
Da) were: TGTLLLILSDVNDNAPIPEPR (mw = 2248, Rt = 11.17, m+ = 541.80, 664.10, 750.35, 750.75, 1124.50, 
1124.90, 1125.60), LLILSDVNDNAPIPEPR (mw = 1876, Rt = 9.93, m+ = 558.30, 643.90, 797.65, 881.60, 985.30, 
965.75, 952.05, 1269.00, 1802.20, 1876.20), ILSDVNDNAPIPEPR (mw = 1650, Rt = 10.09, m+ = 1651.00), 
LSDVNDNAPIPEPR (mw = 1536, Rt = 9.25, m+ = 1537.00) and NDNAPIPEPR (mw = 1122, Rt = 8.79, 
m+ = 444.20, 498.45, 561.95, 562.75, 708.25, 893.40, 1008.45, 1122.50, 1123.50, 1124.40).
Surface plasmon resonance (SPR). Affinity studies were performed on a Sierra Sensors GmbH SPR-2 
instrument. Measurements were performed at 25 °C with a flow rate of 25 μl/min. Carboxymethyl dextran 
matrix high-density sensor chips (SPR-2 Affinity Sensor HC, batch 10-BC-04-154-A, Sierra Sensors) were 
used to immobilise 20 μg/ml HtrA wild-type (wt) in 10 mM HEPES (HEPES buffer 1 M solution, pH 7.3, Fisher 
Scientific) by adding 198 μl amine coupling with an activation solution (200 mM N-ethyl-3-(3-dimethylam
inopropyl)-carbodiimide [EDC] and 50 mM N-hydroxysuccinimide [NHS]). The SPR sensor surface was loaded 
with 100 μl protein and subsequently treated by injecting 192 μl of 1 M ethanolamine at pH 8.5 for inactiva-
tion of excess coupling groups. HBS-P (10 mM HEPES-buffered saline, 150 mM NaCl, 0.005% Tween) served as 
running and sample buffer for peptide measurements. Peptide samples were directly dissolved in HBS-P buffer. 
The experiments with the non-peptidic compounds were performed utilising HBS-PD running buffer (10 mM 
HEPES-buffered saline with 3% DMSO, 150 mM NaCl, 0.005% Tween).
Comparative model of human E-cadherin. We generated a preliminary protein “homology” model 
using a mouse E-cadherin crystal structure as template (PDB ID: 3Q2V; resolution = 3.4 Å; sequence identity to 
human E-cadherin = 82%; coverage = 98%). We used the software Modeller 9.9 after aligning the template with 
the human E-cadherin sequence (D155–I707; UniProt ID: P12830) with ClustalW (www.ebi.ac.uk/Tools/msa/clus-
talw2/)57,58. The final model was selected by analysing the Ramachandran plots of the computed structures, which 
we computed with EBI PDBsum Generate (www.ebi.ac.uk/thornton-srv/databases/pdbsum/Generate.html). The 
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best model had 434 (90%) residues in the most favoured regions, with only one problematic residue (V310). We 
did not perform subsequent molecular dynamics relaxation because we only used the model for visual inspection 
of H. pylori HtrA cleavage sites.
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